TREVI THERAPEUTICS INC's ticker is TRVI and the CUSIP is 89532M101. A total of 56 filers reported holding TREVI THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,268,167 | -6.7% | 1,957,875 | +2.3% | 0.00% | – |
| Q2 2023 | $4,572,696 | +64.8% | 1,913,262 | +27.6% | 0.00% | – |
| Q1 2023 | $2,774,540 | -0.1% | 1,499,751 | +4.2% | 0.00% | – |
| Q4 2022 | $2,778,414 | +36.2% | 1,439,593 | +8.7% | 0.00% | – |
| Q3 2022 | $2,040,000 | +206.3% | 1,324,377 | +459.0% | 0.00% | – |
| Q2 2022 | $666,000 | +98.2% | 236,940 | +55.0% | 0.00% | – |
| Q1 2022 | $336,000 | +202.7% | 152,831 | +7.6% | 0.00% | – |
| Q4 2021 | $111,000 | -42.2% | 142,051 | +4.0% | 0.00% | – |
| Q3 2021 | $192,000 | -36.0% | 136,549 | +2.5% | 0.00% | – |
| Q2 2021 | $300,000 | -16.9% | 133,215 | 0.0% | 0.00% | – |
| Q1 2021 | $361,000 | +12.1% | 133,215 | 0.0% | 0.00% | – |
| Q4 2020 | $322,000 | -40.0% | 133,215 | 0.0% | 0.00% | – |
| Q3 2020 | $537,000 | -41.2% | 133,215 | -4.1% | 0.00% | – |
| Q2 2020 | $914,000 | +84.6% | 138,915 | -7.7% | 0.00% | – |
| Q1 2020 | $495,000 | -12.2% | 150,432 | 0.0% | 0.00% | – |
| Q4 2019 | $564,000 | -16.7% | 150,432 | 0.0% | 0.00% | – |
| Q3 2019 | $677,000 | -23.6% | 150,432 | +27.4% | 0.00% | – |
| Q2 2019 | $886,000 | – | 118,091 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 11,370,376 | $24,787,420 | 1.91% |
| Fairmount Funds Management LLC | 5,163,287 | $11,255,966 | 1.35% |
| Opaleye Management Inc. | 1,705,900 | $3,718,862 | 1.21% |
| Frazier Life Sciences Management, L.P. | 6,881,090 | $15,000,776 | 1.00% |
| VR Adviser, LLC | 3,422,397 | $7,460,825 | 0.78% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 927,415 | $2,021,765 | 0.61% |
| Rubric Capital Management LP | 5,684,420 | $12,392,036 | 0.46% |
| Tejara Capital Ltd | 180,227 | $392,895 | 0.22% |
| PFS Partners, LLC | 100,000 | $218,000 | 0.19% |
| WealthTrust Axiom LLC | 93,500 | $203,830 | 0.07% |